MA44492A - Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif unique - Google Patents
Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif uniqueInfo
- Publication number
- MA44492A MA44492A MA044492A MA44492A MA44492A MA 44492 A MA44492 A MA 44492A MA 044492 A MA044492 A MA 044492A MA 44492 A MA44492 A MA 44492A MA 44492 A MA44492 A MA 44492A
- Authority
- MA
- Morocco
- Prior art keywords
- active agent
- compositions including
- single active
- ophthalmic compositions
- including cyclodextrin
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1619525.7A GB2556082A (en) | 2016-11-18 | 2016-11-18 | Ophthalmic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44492A true MA44492A (fr) | 2019-01-30 |
Family
ID=57993958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044492A MA44492A (fr) | 2016-11-18 | 2017-11-17 | Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif unique |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190328772A1 (fr) |
| EP (1) | EP3432862A1 (fr) |
| JP (1) | JP2020510613A (fr) |
| CN (1) | CN110087635A (fr) |
| AU (1) | AU2017360116B2 (fr) |
| CA (1) | CA3043660A1 (fr) |
| GB (1) | GB2556082A (fr) |
| MA (1) | MA44492A (fr) |
| WO (1) | WO2018091859A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011072141A1 (fr) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions et procédés pour le traitement de la dégénérescence maculaire |
| CN117045653A (zh) | 2013-01-23 | 2023-11-14 | 奥尔德拉医疗公司 | 与毒性醛相关的疾病和治疗 |
| US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
| AU2019319740A1 (en) | 2018-08-06 | 2021-03-25 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| WO2020072621A1 (fr) * | 2018-10-02 | 2020-04-09 | Aldeyra Therapeutics, Inc. | Solutions pour lentilles de contact et kits |
| AU2020232266A1 (en) * | 2019-03-05 | 2021-09-23 | Cornell University | Compositions of matter with activity to remove lipofuscin from retinal cells |
| JP2022530967A (ja) | 2019-05-02 | 2022-07-05 | アルデイラ セラピューティクス， インコーポレイテッド | 多形化合物およびその使用 |
| WO2020223717A1 (fr) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Procédé de préparation d'un piégeur d'aldéhyde et d'intermédiaires |
| US10744153B1 (en) * | 2019-07-01 | 2020-08-18 | Cloudbreak Therapeutics Llc | Compositions and methods for treating meibomian gland dysfunction |
| WO2021231792A1 (fr) | 2020-05-13 | 2021-11-18 | Aldeyra Therapeutics, Inc. | Formulations pharmaceutiques et leurs utilisations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050234018A1 (en) * | 2004-04-15 | 2005-10-20 | Allergan, Inc. | Drug delivery to the back of the eye |
| US7893040B2 (en) * | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
| US8158609B1 (en) * | 2006-11-02 | 2012-04-17 | Novartis Ag | Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen |
| US10463687B2 (en) * | 2011-01-20 | 2019-11-05 | Cornell University | Treatments for retinal disorders |
| US20160151410A1 (en) * | 2013-07-02 | 2016-06-02 | The Trustees Of Columbia University In The City Of New York | Clearance of bioactive lipids from membrane structures by cyclodextrins |
| WO2016168772A1 (fr) * | 2015-04-17 | 2016-10-20 | Sens Research Foundation, Inc. | Composés de cyclodextrine pour la prévention et le traitement du vieillissement |
-
2016
- 2016-11-18 GB GB1619525.7A patent/GB2556082A/en not_active Withdrawn
-
2017
- 2017-11-17 JP JP2019527386A patent/JP2020510613A/ja active Pending
- 2017-11-17 MA MA044492A patent/MA44492A/fr unknown
- 2017-11-17 CA CA3043660A patent/CA3043660A1/fr not_active Abandoned
- 2017-11-17 EP EP17807898.6A patent/EP3432862A1/fr not_active Withdrawn
- 2017-11-17 AU AU2017360116A patent/AU2017360116B2/en not_active Ceased
- 2017-11-17 CN CN201780071527.5A patent/CN110087635A/zh active Pending
- 2017-11-17 US US16/462,129 patent/US20190328772A1/en not_active Abandoned
- 2017-11-17 WO PCT/GB2017/000166 patent/WO2018091859A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020510613A (ja) | 2020-04-09 |
| GB2556082A (en) | 2018-05-23 |
| CA3043660A1 (fr) | 2018-05-24 |
| US20190328772A1 (en) | 2019-10-31 |
| CN110087635A (zh) | 2019-08-02 |
| WO2018091859A1 (fr) | 2018-05-24 |
| EP3432862A1 (fr) | 2019-01-30 |
| AU2017360116B2 (en) | 2019-12-12 |
| GB201619525D0 (en) | 2017-01-04 |
| AU2017360116A1 (en) | 2019-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44492A (fr) | Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif unique | |
| MA45153A (fr) | Dérivés de carbonucléosides substitués utiles en tant qu'agents anticancéreux | |
| MA47123A (fr) | Dérivés de benzooxazole en tant qu'mmunomodulateurs | |
| EP3386981A4 (fr) | Hétérocycles utiles en tant qu'agents anticancereux | |
| EP3442973A4 (fr) | Nouveaux composés utilisés en tant qu'inhibiteurs de l'autotaxine et compositions pharmaceutiques les comprenant | |
| MA48994A (fr) | Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1 | |
| EP3784665A4 (fr) | Dérivés de pyridazine en tant qu'agents de dégradation de smarca2/4 | |
| EP3687543A4 (fr) | Agents pharmaceutiques en combinaison en tant qu'inhibiteurs de rsv | |
| MA48765A (fr) | Cyanopyrrolidines substituées par sulfonamide ayant une activité en tant qu'inhibiteurs de dub | |
| MA41140A (fr) | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg | |
| MA47125A (fr) | Dérivés de pyrazole en tant qu'inhibiteurs de malt1 | |
| EP3953331A4 (fr) | Pyrazolesulfonamides en tant qu'agents antitumoraux | |
| MA42990A (fr) | Composés utiles en tant qu'immunomodulateurs | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| MA45377A (fr) | Composés hétérocycliques en tant qu'agents antibacteriens | |
| MA46981A (fr) | Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine | |
| MA51232A (fr) | Indane-amines utiles en tant qu'antagonistes de pd-l1 | |
| EP3324856A4 (fr) | Compositions se fluidifiant par cisaillement en tant qu'agent embolique intravasculaire | |
| EP3886879A4 (fr) | Plaquettes en tant qu'agents de livraison | |
| EP3694867C0 (fr) | Dinucléotides cycliques utilisés en tant qu'agents anticancéreux | |
| MA46878A (fr) | Composés de benzodiazolium en tant qu'inhibiteurs d'enac | |
| MA41341A (fr) | Dérivés indole utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| EP3334719A4 (fr) | Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques | |
| EP3487509A4 (fr) | Désinfectants topiques émollients |